Potential benefits of immunomodulator use with vedolizumab for maintenance of remission in ulcerative colitis

BACKGROUND AND AIM: This study aimed to determine the efficacy and safety of vedolizumab treatment with or without concomitant immunomodulator use in Japanese patients with moderate‐to‐severe ulcerative colitis. METHODS: Among enrolled patients in a phase 3 study conducted in Japan (clinicaltrials.g...

Descripción completa

Detalles Bibliográficos
Autores principales: Naganuma, Makoto, Watanabe, Kenji, Motoya, Satoshi, Ogata, Haruhiko, Matsui, Toshiyuki, Suzuki, Yasuo, Ursos, Lyann, Sakamoto, Shigeru, Shikamura, Mitsuhiro, Hori, Tetsuharu, Fernandez, Jovelle, Watanabe, Mamoru, Hibi, Toshifumi, Kanai, Takanori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Regular Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293068/
https://www.ncbi.nlm.nih.gov/pubmed/34409654
http://dx.doi.org/10.1111/jgh.15667

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293068/
https://www.ncbi.nlm.nih.gov/pubmed/34409654
http://dx.doi.org/10.1111/jgh.15667

Ejemplares similares